Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies

Andres Forero-Torres; Nancy L. Bartlett; Robert B. Berryman; Robert Chen; Jeffrey V. Matous; Michelle A. Fanale; Owen A. O'Connor; Randal Olshefski; Scott E. Smith; Dirk Huebner; Pamela L. Levine; Laurie E. Grove; Ajay K. Gopal

doi:10.3109/10428194.2014.951843

Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies

Andres Forero-Torres
, Nancy L. Bartlett
, Robert B. Berryman
, Robert Chen
, Jeffrey V. Matous
, Michelle A. Fanale
, Owen A. O'Connor
, Randal Olshefski
, Scott E. Smith
, Dirk Huebner
, Pamela L. Levine
, Laurie E. Grove
, Ajay K. Gopal

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1151-1153
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	56
Issue number	4
DOIs	https://doi.org/10.3109/10428194.2014.951843
State	Published - Apr 1 2015

Access to Document

10.3109/10428194.2014.951843

Cite this

Forero-Torres, A., Bartlett, N. L., Berryman, R. B., Chen, R., Matous, J. V., Fanale, M. A., O'Connor, O. A., Olshefski, R., Smith, S. E., Huebner, D., Levine, P. L., Grove, L. E., & Gopal, A. K. (2015). Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies. Leukemia and Lymphoma, 56(4), 1151-1153. https://doi.org/10.3109/10428194.2014.951843

@article{05f2d52c396f47999c7b2660d04d4835,

title = "Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies",

author = "Andres Forero-Torres and Bartlett, \{Nancy L.\} and Berryman, \{Robert B.\} and Robert Chen and Matous, \{Jeffrey V.\} and Fanale, \{Michelle A.\} and O'Connor, \{Owen A.\} and Randal Olshefski and Smith, \{Scott E.\} and Dirk Huebner and Levine, \{Pamela L.\} and Grove, \{Laurie E.\} and Gopal, \{Ajay K.\}",

year = "2015",

month = apr,

day = "1",

doi = "10.3109/10428194.2014.951843",

language = "English",

volume = "56",

pages = "1151--1153",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

number = "4",

}

Forero-Torres, A, Bartlett, NL, Berryman, RB, Chen, R, Matous, JV, Fanale, MA, O'Connor, OA, Olshefski, R, Smith, SE, Huebner, D, Levine, PL, Grove, LE & Gopal, AK 2015, 'Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies', Leukemia and Lymphoma, vol. 56, no. 4, pp. 1151-1153. https://doi.org/10.3109/10428194.2014.951843

TY - JOUR

T1 - Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies

AU - Forero-Torres, Andres

AU - Bartlett, Nancy L.

AU - Berryman, Robert B.

AU - Chen, Robert

AU - Matous, Jeffrey V.

AU - Fanale, Michelle A.

AU - O'Connor, Owen A.

AU - Olshefski, Randal

AU - Smith, Scott E.

AU - Huebner, Dirk

AU - Levine, Pamela L.

AU - Grove, Laurie E.

AU - Gopal, Ajay K.

PY - 2015/4/1

Y1 - 2015/4/1

UR - https://www.scopus.com/pages/publications/84929104906

U2 - 10.3109/10428194.2014.951843

DO - 10.3109/10428194.2014.951843

M3 - Article

C2 - 25110824

AN - SCOPUS:84929104906

SN - 1042-8194

VL - 56

SP - 1151

EP - 1153

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 4

ER -

Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies

Access to Document

Other files and links

Cite this